MPOX
JOIN

Addendum to Priority List of Adverse Events of Special Interest: COVID-19

The Coalition for Epidemic Preparedness Innovations (CEPI) has contracted with the Brighton Collaboration, through the Task Force for Global Health (TFGH), to harmonize the safety assessment of CEPI-funded vaccines via its Safety Platform for Emergency vACcines (SPEAC) Project. As part of its landscape analysis of COVID-19, a document describing the methods and results SPEAC used to arrive at the list of adverse events of special interest (AESI) was posted in June. An addendum to this document is now available.

See Below to download the Addendum to the Priority List of Adverse Events of Special Interest: COVID-19 document.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

 

More SAFETY TEMPLATES

Comirnaty COVID-19 mRNA vaccine: standardized template with key considerations for a benefit-risk assessment

August 27, 2024

Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 viruses

October 26, 2023

Live-attenuated viral vaccines: standardized template for collection of key information for benefit-risk assessment

October 13, 2023

Viral vector vaccines: standardized template for collection of key information for benefit-risk assessment

October 13, 2023

Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment

October 13, 2023

Modified Vaccinia Ankara (MVA) vaccine platform: standardized template for collection of key information for risk/benefit assessment

October 4, 2023
View All

More Posts

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

Linkedin

© Brighton Collaboration  2023. All rights reserved.